Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma

Immunological tolerance of myeloma cells represents a critical obstacle in achieving long-term disease-free survival for multiple myeloma (MM) patients. Over the past two decades, remarkable preclinical efforts to understand MM biology have led to the clinical approval of several targeted and immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnstone, Megan, Vinaixa, Delaney, Turi, Marcello, Morelli, Eugenio, Anderson, Kenneth Carl, Gulla, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406519/
https://www.ncbi.nlm.nih.gov/pubmed/36010596
http://dx.doi.org/10.3390/cells11162519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406519/
https://www.ncbi.nlm.nih.gov/pubmed/36010596
http://dx.doi.org/10.3390/cells11162519

Ejemplares similares